title: Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment.
abstract: Eradication of H pylori and cure of peptic ulcer disease are possible if effective regimens are used correctly. Treatment markedly improves clinical outcomes and significantly decreases cost of care. As primary care physicians take a larger role in management of these infections, they need to understand the importance of identifying and treating patients with H pylori-associated peptic ulcer disease. Successful treatment of this infection depends on the appropriate antimicrobial therapy and patient compliance with the chosen regimen.
authors.affiliation: Department of Medicine, University of Southern California School of Medicine, Los Angeles 90023, USA.
authors.forename: L
authors.initials: L
authors.lastname: Laine
authors.forename: A M
authors.initials: AM
authors.lastname: Fendrick
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D017291:Clarithromycin